In recent years, targeted therapy of ErbB2 has become a research hotspot in breast cancer treatment, and the upregulation of ErbB2 receptor was closely related to the occurrence of breast cancer (Xu et al., 2019). The gene discussed is ERBB2; the disease is breast cancer.